The role of combination medical therapy in benign prostatic hyperplasia-Reference-Cited by-同舟云学术

The role of combination medical therapy in benign prostatic hyperplasia

Published:2008-11-10 Issue:S3 Volume:20 Page:S33-S43
ISSN:0955-9930
Container-title:International Journal of Impotence Research
language:en
Short-container-title:Int J Impot Res

Author:

Greco K A,McVary K T

Publisher

Springer Science and Business Media LLC

Subject

Urology

Link

http://www.nature.com/articles/ijir200851.pdf

Reference49 articles.

1. American Urological Association. Guideline on the Management of Benign Prostatic Hyperplasia (BPH). www.auanet.org/guidelines/bph.cfm (updated 2006).

2. Welch G, Weinger K, Barry MJ . Quality-of-life impact of lower urinary tract symptom severity: results from the health professionals follow-up study. Urology 2002; 59: 245–250.

3. Sung JC, Curtis LH, Schulman KA, Albala DM . Geographic variations in the use of medical and surgical therapies for benign prostatic hyperplasia. J Urol 2006; 175: 1023–1027.

4. McVary KT . A review of combination therapy in patients with benign prostatic hyperplasia. Clin Ther 2007; 29: 387–398.

5. Berry SJ, Coffey DS, Walsh PC, Ewing LL . The development of human prostatic hyperplasia with age. J Urol 1984; 132: 474–479.

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Response Surface Methodology (RSM) approach to formulate and optimize the bilayer combination tablet of Tamsulosin and Finasteride;Saudi Pharmaceutical Journal;2024-03

2. A novel eco-friendly HPLC method with dual detection modes for versatile quantification of dutasteride and silodosin in pharmaceutical formulation, dissolution testing and spiked human plasma;Microchemical Journal;2024-02

3. State-of-the-art mathematically induced filtration approaches for smart spectrophotometric assessment of silodosin and solifenacin mixture in their new challenging formulation: Multi-tool greenness and whiteness evaluation;Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy;2024-02

4. Urinary microbiota is associated to clinicopathological features in benign prostatic hyperplasia;The Prostate;2023-11-13

5. Urinary microbiota is associated to clinicopathological features in benign prostatic hyperplasia;2023-08-21